Association of central pulse pressure with contrast-induced nephropathy and clinical outcomes in patients undergoing coronary intervention

Journal of Hypertension

Volumn 31, Issue 11, 2013, Pages 2187-2194

  Huang, Shao Sung ^a   Huang, Po Hsun ^a   Leu, Hsin Bang ^a   Wu, Tao Cheng ^a   Lin, Shing Jong ^a   Chen, Jaw Wen ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

contrast induced nephropathy; outcome; percutaneous coronary intervention; pulse pressure

Indexed keywords

CONTRAST MEDIUM; CREATININE;

ADVERSE EFFECTS; AGED; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; HUMAN; INCIDENCE; KIDNEY DISEASES; KIDNEY FUNCTION TEST; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHYSIOLOGY; REGRESSION ANALYSIS; RISK; STROKE; TIME;

AGED; BLOOD PRESSURE; CONTRAST MEDIA; CREATININE; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; REGRESSION ANALYSIS; STROKE; TIME FACTORS;

EID: 84885641046     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283641023     Document Type: Article

References (29)

1. McCullough PA, Soman SS. Contrast-induced nephropathy. Crit Care Clin 2005; 21:261-280.
2. Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol 2004; 183:1673-1689.
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39:930-936.
4. Cox CD, Tsikouris JP. Preventing contrast nephropathy: what is the best strategy? A review of the literature. J Clin Pharmacol 2004; 44:327-337.
5. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med 1997; 103:368-375.
6. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous interventions. J Am Coll Cardiol 2002; 39:1113-1119.
7. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105:2259-2264.
8. Safar ME. Pulse pressure, arterial stiffness, and cardiovascular risk. Curr Opin Cardiol 2000; 15:258-263.
9. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107:2864-2869.
10. Ni Y, Wang H, Hu D, Zhang W. The relationship between pulse velocity and pulse pressure in Chinese patients with essential hypertension. Hypertens Res 2003; 26:871-874.
11. Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol 2002; 13:2776-2782.
12. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17:2937-2944.
13. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989; 320:143-149.
14. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 2003; 76:513-518.
15. Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA. CIN Consensus Working Panel. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006; 98:14K-20K.
16. Verhave JC, Fesler P, du Cailar G, Ribstein J, Safar ME, Mimran A. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension 2005; 45:586-591.
17. Mitchell GF. Increased aortic stiffness: An unfavorable cardiorenal connection. Hypertension 2004; 43:151-153.
18. Safar ME. Peripheral pulse pressure, large arteries, and microvessels. Hypertension 2004; 44:121-122.
19. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension 2004; 43:163-168.
20. Loutzenhiser R, Bidani A, Chilton L. Renal myogenic response: kinetic attributes and physiological role. Circ Res 2002; 90:1316-1324.
21. Schillaci G, Pirro M, Mannarino MR, Pucci G, Savarese G, Franklin SS, et al. Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension 2006; 48:616-621.
22. Wang KL, Cheng HM, Chuang SY, Spurgeon HA, Ting CT, Lakatta EG, et al. Central or peripheral systolic or pulse pressure: which best relates to target-organs and future mortality? J Hypertens
23. Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD, et al. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension 2009; 54:375-383.
24. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al., CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225.
25. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al., ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet 2005; 366:895-906.
26. Mitchell GF, Izzo JL Jr, Lacourcière Y, Ouellet JP, Neutel J, Qian C, et al. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation 2002; 105:2955-2961.
27. Williams C, Kingwell BA, Burke K, McPherson J, Dart AM. Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype.Am J Clin Nutr 2005; 82:26-31
28. Wang CP, Lu LF, Tsai IT, Yang CY, Yu TH, Hung WC, et al. Roles of serum total p-cresylsulfate and chronic kidney disease in coronary atherosclerotic burden in acute coronary syndrome patients. Acta Cardiol Sin 2012; 28:297-305.
29. Huang CC, Chen JW. Contemporary management of coronary artery disease and acute coronary syndrome in patients with chronic kidney disease and end-stage renal disease. Acta Cardiol Sin 2013; 29:132-141.